Directly observed treatment for tuberculosis

BMJ 1996; 313 doi: 10.1136/bmj.313.7048.45a (Published 6 July 1996)
Cite this as: BMJ 1996;313:45.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Could be provided by community pharmacists supervising consumption of methadone

  1. Louise Sell,
  2. Emily Finch,
  3. Michael Farrell,
  4. Janie Sheridan,
  5. John Strang
  1. Clinical lecturer Clinical lecturer Senior lecturer Research pharmacist Professor National Addiction Centre, Institute of Psychiatry, London SE5 8AF

    EDITOR,—Increasing rates of tuberculosis are cause for concern.1 Since increasing rates are reported in homeless people and those with HIV infection, intravenous drug users are at risk. While there is no evidence of high rates of tuberculosis in British drug users, rising rates have been reported in other European countries.2 Britain needs effective strategies for prevention and for treating those affected. A drug user with …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL